Effects of hypericin on the structure and aggregation properties of β-amyloid peptides.
We have determined the secondary structure of 1-40 β-amyloid peptides by Fourier-transform infrared spectroscopy (FTIR) and characterized the peptide photophysical properties before and after self-assembly by using intrinsic tyrosine steady-state and time-resolved fluorescence. All measurements were performed in the presence and absence of hypericin (Hyp), an exogenous natural polycyclic pigment that has been shown to inhibit fibril formation and has also been used as a fluorescent probe. We monitored the time course of the aggregation process measuring 405 nm light diffusion at 90° and used thioflavin T to reveal the presence of fibrils. FTIR quantitative analysis evidenced a prevalent random conformation at t = 0 with and without Hyp. Fibrils showed a predominant parallel β-sheet structure and a small percentage of α-helix. The results of fluorescence measurements showed that Hyp does significantly interact with peptides in β-sheet conformation. In conclusion, hypericin does hinder the formation of fibrils, but the percentages of parallel β-sheets were not significantly different from those found in samples not treated with Hyp.
Bramanti
Emilia
E
Laboratory of Instrumental Analytical Chemistry, Istituto per i Processi Chimico-Fisici, CNR, Italian National Research Council, Via G Moruzzi 1, 56124 Pisa, Italy.
Lenci
Francesco
F
Sgarbossa
Antonella
A
D016229:Amyloid beta-Peptides / Q000737:chemistry* / Q000378:metabolism*; D000873:Anthracenes; D010446:Peptide Fragments / Q000737:chemistry* / Q000378:metabolism*; D010569:Perylene / Q000031:analogs & derivatives* / Q000494:pharmacology; D055503:Protein Multimerization / Q000187:drug effects*; D020836:Protein Structure, Quaternary / Q000187:drug effects; D017433:Protein Structure, Secondary / Q000187:drug effects; D017550:Spectroscopy, Fourier Transform Infrared
D016229:Amyloid beta-Peptides; D000873:Anthracenes; D010446:Peptide Fragments; C078592:amyloid beta-protein (1-40); D010569:Perylene; C004965:hypericin
Photochem Photobiol. 1995 Jul;62(1):199-204
7638267
Biochemistry. 2009 Sep 8;48(35):8322-34
19645507
Biochim Biophys Acta. 1992 Apr 8;1120(2):123-43
1373323
Nat Struct Mol Biol. 2007 Dec;14(12):1157-64
18059284
Nat Struct Mol Biol. 2008 Jun;15(6):558-66
18511942
Protein Sci. 2006 Apr;15(4):862-70
16600970
J Biomed Mater Res. 1989 Jun;23(6):549-69
2738075
Biochemistry. 2010 Feb 23;49(7):1358-60
20070125
Biopolymers. 1976 Apr;15(4):607-25
1252597
Biochemistry. 2005 Oct 11;44(40):13365-76
16201761
Biopolymers. 1996 May;38(5):639-53
8722232
FEBS Lett. 2009 Aug 20;583(16):2593-9
19376114
Biophys J. 2009 Feb;96(3):1091-104
19186145
Biopolymers. 1990;30(13-14):1259-71
1707690
FASEB J. 2004 Sep;18(12):1366-72
15333579
Biochim Biophys Acta. 2004 Dec 24;1739(1):5-25
15607113
Proteins. 2006 Aug 1;64(2):355-62
16705651
Biochim Biophys Acta. 2004 May 6;1698(2):131-53
15134647
Biochem Biophys Res Commun. 1999 Aug 19;262(1):152-6
10448084
Biophys J. 2007 May 15;92(10):3448-58
17325005
Biopolymers. 2004;76(5):435-45
15478139
Biopolymers. 1976 Jan;15(1):203-18
1119
Chem Biol Drug Des. 2006 Jan;67(1):27-37
16492146
Nat Neurosci. 2005 Jan;8(1):79-84
15608634
Q Rev Biophys. 2006 May;39(2):167-201
16978447
Biopolymers. 1975 Apr;14(4):679-94
1156632
J Biol Chem. 2007 Apr 6;282(14):10311-24
17284452
Biochemistry. 1993 Jan 19;32(2):389-94
8422346
J Biol Chem. 1996 Feb 23;271(8):4086-92
8626745
Adv Protein Chem. 1986;38:181-364
3541539
Biopolymers. 1980 Jan;19(1):31-6
6989414
J Neurochem. 2003 Oct;87(1):172-81
12969264
J Phys Chem B. 2009 Oct 8;113(40):13429-36
19754054
Angew Chem Int Ed Engl. 2003 Jun 6;42(22):2462-81
12800163
FEBS Lett. 2008 Oct 15;582(23-24):3288-92
18805418
Amyloid. 2000 Sep;7(3):166-78
11019857
Photochem Photobiol. 2001 Aug;74(2):196-200
11547554
Eur J Biochem. 2002 Jul;269(14):3362-71
12135474
FEBS J. 2005 Dec;272(23):5971-8
16302962
J Neurosci. 2005 Mar 9;25(10):2455-62
15758153